Rendon R - Search Results

1

Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.

Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Kassouf W. Kool R, et al. Among authors: rendon r. Eur Urol Oncol. 2024 Feb 6:S2588-9311(24)00040-3. doi: 10.1016/j.euo.2024.01.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38326142

2

Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

Kassouf W, Kamat AM, Zlotta A, Bochner BH, Moore R, So A, Izawa J, Rendon RA, Lacombe L, Aprikian AG. Kassouf W, et al. Among authors: rendon ra. Can Urol Assoc J. 2010 Jun;4(3):168-73. doi: 10.5489/cuaj.10051. Can Urol Assoc J. 2010. PMID: 20514279 Free PMC article. No abstract available.

3

Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience.

Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Kassouf W. Yafi FA, et al. Among authors: rendon r. BJU Int. 2011 Aug;108(4):539-45. doi: 10.1111/j.1464-410X.2010.09912.x. Epub 2010 Dec 16. BJU Int. 2011. PMID: 21166753

4

Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

Mason RJ, Abdolell M, Trottier G, Pringle C, Lawen JG, Bell DG, Jewett MA, Klotz L, Rendon RA. Mason RJ, et al. Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22. Eur Urol. 2011. PMID: 21353376

5

Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.

Chalasani V, Kassouf W, Chin JL, Fradet Y, Aprikian AG, Fairey AS, Estey E, Lacombe L, Rendon R, Bell D, Cagiannos I, Drachenberg D, Lattouf JB, Izawa JI. Chalasani V, et al. Among authors: rendon r. Can Urol Assoc J. 2011 Apr;5(2):83-7. doi: 10.5489/cuaj.10040. Can Urol Assoc J. 2011. PMID: 21470529 Free PMC article.

6

Active surveillance of small renal masses: progression patterns of early stage kidney cancer.

Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A. Jewett MA, et al. Among authors: rendon ra. Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1. Eur Urol. 2011. PMID: 21477920 Clinical Trial.

7

Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA. Nam RK, et al. Among authors: rendon r. J Clin Oncol. 2011 Aug 1;29(22):2959-64. doi: 10.1200/JCO.2010.32.6371. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690464

8

Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.

Fairey AS, Kassouf W, Aprikian AG, Chin JL, Izawa JI, Fradet Y, Lacombe L, Rendon RA, Bell D, Cagiannos I, Drachenberg DE, Lattouf JB, Estey EP. Fairey AS, et al. Urol Oncol. 2012 Nov-Dec;30(6):825-32. doi: 10.1016/j.urolonc.2011.07.014. Epub 2011 Sep 1. Urol Oncol. 2012. PMID: 21889368

9

Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?

Kotb AF, Kovac E, Kassouf W, Chin J, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Aprikian AG. Kotb AF, et al. Among authors: rendon r. World J Urol. 2012 Dec;30(6):761-7. doi: 10.1007/s00345-012-0832-2. World J Urol. 2012. PMID: 22293934

10

The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.

Mason RJ, Kassouf W, Bell DG, Lacombe L, Kapoor A, Jacobsen N, Fairey A, Izawa J, Black P, Tanguay S, Chin J, So A, Lattouf JB, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Fradet Y, Rendon RA. Mason RJ, et al. Urology. 2012 Apr;79(4):840-5. doi: 10.1016/j.urology.2011.11.058. Epub 2012 Feb 25. Urology. 2012. PMID: 22365453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page